Enterocin AS-48

General Information


DRACP ID  DRACP03530

Peptide Name   Enterocin AS-48

Sequence  MAKEFGIPAAVAGTVLNVVEAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAW

Sequence Length  70

UniProt ID  Q47765 

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03530

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C328H549N87O89S

Absent amino acids  CDHQ

Common amino acids  A

Mass  839853

Pl  10.83

Basic residues  10

Acidic residues  4

Hydrophobic residues  35

Net charge  6

Boman Index  -61

Hydrophobicity  53.86

Aliphatic Index  117.14

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  12490

Absorbance 280nm  181.01

Polar residues  19

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29987141

Title  Synergistic activity of AS-48 with ethambutol was observed on M tuberculosis-infected macrophages

Doi Not available

Year  2018

Literature 2

Pubmed ID 20833793

Title  Insights into the functionality of the putative residues involved in enterocin AS-48 maturation

Doi Not available

Year  2010

Literature 3

Pubmed ID 19958277

Title  Conformational stability and activity of circular Enterocin AS-48 derivatives

Doi Not available

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6694

DRACP is developed by Dr.Zheng's team.